UK Markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.02-0.18 (-0.56%)
At close: 04:00PM EST
32.41 +0.39 (+1.22%)
After hours: 04:23PM EST
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts1051011
Avg. Estimate-0.55-0.5-1.28-2.16
Low estimate-0.81-0.86-1.67-4.12
High estimate-0.06-0.150.420.47
Year ago EPS-0.61-0.6-1.36-1.28
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts1051111
Avg. Estimate67.93M62.03M272.35M248.94M
Low estimate24.4M32.5M236.1M93.6M
High estimate225.3M92M437M463.8M
Year ago sales38.28MN/A138.29M272.35M
Sales growth (year/est)77.40%N/A96.90%-8.60%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.1-0.45-0.08-0.51
Actual EPS-0.61-0.60.41-0.68
Difference-0.51-0.150.49-0.17
Surprise %-510.00%-33.30%612.50%-33.30%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.55-0.5-1.28-2.16
7 days ago-0.55-0.5-1.28-2.11
30 days ago-0.55-0.5-1.28-2.11
60 days ago-0.49-0.5-1.17-1.87
90 days ago-0.44-0.5-1.15-1.97
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesARWRIndustrySector(s)S&P 500
Current qtr.9.80%N/AN/AN/A
Next qtr.16.70%N/AN/AN/A
Current year5.90%N/AN/AN/A
Next year-68.80%N/AN/AN/A
Next 5 years (per annum)7.33%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A